Literature DB >> 15959874

Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model.

Janee Gelineau-van Waes1, Lois Starr, Joyce Maddox, Francisco Aleman, Kenneth A Voss, Justin Wilberding, Ronald T Riley.   

Abstract

BACKGROUND: Fumonisin B1 (FB1) is a mycotoxin produced by the fungus Fusarium verticillioides, a common contaminant of corn worldwide. FB1 disrupts sphingolipid biosynthesis by inhibiting the enzyme ceramide synthase, resulting in an elevation of free sphingoid bases and depletion of downstream glycosphingolipids. A relationship between maternal ingestion of FB1-contaminated corn during early pregnancy and increased risk for neural tube defects (NTDs) has recently been proposed in human populations around the world where corn is a dietary staple. The current studies provide an in vivo mouse model of FB1 teratogenicity.
METHODS: Pregnant LM/Bc mice were injected with increasing doses of FB1 on GD 7.5 and 8.5, and exposed fetuses were examined for malformations. Sphingolipid profiles and (3)H-folate concentrations were measured in maternal and fetal tissues. Immunohistochemical expression of the GPI-anchored folate receptor (Folbp1) and its association with the lipid raft component, ganglioside GM1, were characterized. Rescue experiments were performed with maternal folate supplementation or administration of gangliosides.
RESULTS: Maternal FB1 administration (20 mg/kg of body weight) during early gestation resulted in 79% NTDs in exposed fetuses. Sphingolipid profiles were significantly altered in maternal and embryonic tissues following exposure, and (3)H-folate levels and immunohistochemical expression of Folbp1 were reduced. Maternal folate supplementation partially rescued the NTD phenotype, whereas GM1 significantly restored folate concentrations and afforded almost complete protection against FB1-induced NTDs.
CONCLUSIONS: Maternal FB1 exposure altered sphingolipid metabolism and folate concentrations in LM/Bc mice, resulting in a dose-dependent increase in NTDs that could be prevented when adequate folate levels were maintained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15959874     DOI: 10.1002/bdra.20148

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  43 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells.

Authors:  Phillip Callihan; Nicholas C Zitomer; Michael V Stoeling; Perry C Kennedy; Kevin R Lynch; Ronald T Riley; Shelley B Hooks
Journal:  Neuropharmacology       Date:  2011-10-15       Impact factor: 5.250

3.  Transgenic versus conventional corn: fate of fumonisins during industrial dry milling.

Authors:  Jaqueline Gozzi Bordini; Mario Augusto Ono; Glauco Tironi Garcia; Édio Vizoni; Ismael Rodrigues Amador; Melissa Tiemi Hirozawa; Elisabete Yurie Sataque Ono
Journal:  Mycotoxin Res       Date:  2019-01-31       Impact factor: 3.833

Review 4.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

5.  Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity.

Authors:  John T Szilagyi; Anna M Vetrano; Jeffrey D Laskin; Lauren M Aleksunes
Journal:  Placenta       Date:  2017-04-12       Impact factor: 3.481

Review 6.  It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.

Authors:  Erhard Bieberich
Journal:  Neurochem Res       Date:  2012-01-14       Impact factor: 3.996

Review 7.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

8.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

9.  Interactions of Bacillus mojavensis and Fusarium verticillioides with a benzoxazolinone (BOA) and its transformation product, APO.

Authors:  Charles W Bacon; Dorothy M Hinton; Anthony E Glenn; Francisco A Macías; David Marin
Journal:  J Chem Ecol       Date:  2007-09-25       Impact factor: 2.626

10.  Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodies.

Authors:  Hyejung Park; Christopher A Haynes; Alison V Nairn; Michael Kulik; Stephen Dalton; Kelley Moremen; Alfred H Merrill
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.